In the biotechnology sector, BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) and Seattle Genetics Inc. (NASDAQ: SGEN) are competing with each other. We will compare them and contrast their profitability, recommendations for analysts, risk, ownership of institutions, dividends, earnings, and valuation.
A 2.05 alpha Volatility & Risk suggests that BioCryst Pharmaceuticals Inc. is 105.00 times more volatile than Standard and Poor's....
Tags : biotechnology ,
comments (0)